MedPath

The feasibility study of cisplatin-containing combination chemotherapy with a short hydration regimen for advanced gastric cancer

Phase 2
Recruiting
Conditions
advanced or recurrent gastric cancer
Registration Number
JPRN-UMIN000009499
Lead Sponsor
Department of gastroenterology, Okayama University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1.with severe diseases (hepatic failure, pulmonary disease, heart failure, hematologic disorder) 2.with uncontrollable DM 3.with active double cancer 4.pregnant and/or nursing women 5.symptomatic psychological disease 6.HBs-Ag positive and/or HCV-Ab positive 7.with active infection 8.any other patient whom the physician in charge of the study judges to be unsuitable

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of nephrotoxicity
Secondary Outcome Measures
NameTimeMethod
Incidence of adverse event other than nephrotoxicity, response rate, progression free survival, Cisplatin treatment completion rate
© Copyright 2025. All Rights Reserved by MedPath